Design, Synthesis, Molecular Docking, and Pharmacological Evaluation of 2-Aminobenzimidazole Derivatives as Potential Anti-Alzheimer’s Agents
Open Access
- 10 October 2025
- journal article
- Published by Indus Publishers in Indus Journal of Bioscience Research
- Vol. 3 (10) , 176-184
Abstract
Some new aminobenzimidazole derivatives were synthesized and investigated their pharmacological potential including anti-oxidant and acetylcholinesterase inhibitory activity to treat AD. A series of eight benzimidazole derivatives was synthesized by two-step procedure. All the synthesized derivatives were characterized by spectroscopic techniques such as NMR (1H-NMR) and FTIR. All the compounds were further evaluated for their anti-oxidant and AchE inhibitory potential. Four compounds 2g, 2a and 2b have shown potent inhibitory activity as 91.86%, 88.69%, and 81.91% respectively. Among eight synthesized compounds, the highest anti-oxidant activity 86.64% was exhibited by compound 2d, and compound 2d showed higher potency with IC50 of 4.96 µg/mL. Next docking studies were performed by using Auto Dock Vina program for which acetylcholinesterase has been used as target. Compounds 2e, 2a and 2d have exhibited the highest binding affinity with acetylcholinesterase among the synthesized derivatives with a value of -10.5 kcal/mol, -10.4 kcal/mol and -10.3 kcal/mol respectively. The results indicated that benzimidazole derivatives could be used as lead molecules for acetylcholinesterase inhibitors and can be further evaluated for their therapeutic potential for the treatment of AD.Keywords
This publication has 18 references indexed in Scilit:
- Synthesis of new nicotintaldehyde derivatives via Pd(0) catalyzed suzuki coupling with structural characterization and co-combined computational-experimental evaluation against oral pathogensScientific Reports, 2025
- RETRACTED ARTICLE: Novel acetamide derivatives of 2-aminobenzimidazole prevent inflammatory arthritis in rats via suppression of pro-inflammatory mediatorsInflammopharmacology, 2022
- Isatin-hydrazide conjugates as potent α-amylase and α-glucosidase inhibitors: Synthesis, structure and in vitro evaluationsBioorganic Chemistry, 2021
- Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's diseaseClinical Biochemistry, 2019
- Investigation of the toxicological and inhibitory effects of some benzimidazole agents on acetylcholinesterase and butyrylcholinesterase enzymesArchives of Physiology and Biochemistry, 2019
- Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s drug candidatesJournal of Enzyme Inhibition and Medicinal Chemistry, 2018
- Mannich‐Benzimidazole Derivatives as Antioxidant and Anticholinesterase Inhibitors: Synthesis, Biological Evaluations, and Molecular Docking StudyArchiv der Pharmazie, 2017
- One-pot synthesis of amides from carboxylic acids activated using thionyl chlorideRSC Advances, 2016
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEThe Lancet, 1976
- The Chemistry of the Benzimidazoles.Chemical Reviews, 1951